Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
A new USC study suggests that publicly insured individuals who are most likely to benefit from new drugs for diabetes and obesity are less likely to get them than those with private insurance
Instead, dosage decisions usually depend on factors like how severe the symptoms are, how well the treatment is working, and any side effects that might occur
One Reuters story (Aug 2025) reported that some insured Americans on GLP-1 weight drugs cut doses and maybe vacations to afford treatment ( [4] )
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context regarding genetic predispositions in metabolic and thyroid-related pathways, such as variants in FTO and MC4R genes that influence weight regulation and thyroid hormone metabolism
Wellness scores pull them toward better choices
US$ 27.37
US$ 28.97
US$ 27.92
US$ 28.56
US$ 29.23
US$ 28.22
